Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

C3_PANCREAS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C25 Hospital discharge: ICD-9 — 157 Hospital discharge: ICD-8 — 157 Cause of death: ICD-10 — C25 Cause of death: ICD-9 — 157 Cause of death: ICD-8 — 157 Cancer registry: Topography ICD-O-3 — C25 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3233
4. Check minimum number of events None	3233
5. Include endpoints None	3233
6. Filter based on genotype QC (FinnGen only)	3233

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_PANCREAS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C25
HD_ICD_9	157
HD_ICD_8	157
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C25
COD_ICD_9	157
COD_ICD_8	157
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C25
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3233	1363	1870
Unadjusted period prevalence (%)	0.67	0.46	0.82
Median age at first event (years)	70.91	70.55	71.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2061: Matched controls
20610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

323.0

478

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

323.0

356

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

124.2

323.0

569

A03FA01

ATC

metoclopramide; systemic, rectal

21.1

323.0

1140

1142

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

112.1

323.0

770

109

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

323.0

907

Z51.5

ICD-10 Finland

Palliative care

40.2

323.0

634

225

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

308

A04AA02

ATC

granisetron; systemic, transdermal

2257.3

323.0

626

H02AB02

ATC

dexamethasone; systemic

143.6

323.0

651

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

323.0

583

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2464.4

323.0

528

JLC30

NOMESCO Finland

Pancreatoduodenectomy

1010.6

323.0

339

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

1267

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

658.5

323.0

379

N02AA05

ATC

oxycodone; systemic

13.2

323.0

989

1349

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

323.0

332

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

323.0

1186

A09AA02

ATC

multienzymes (lipase, protease etc.)

73.4

323.0

630

123

L01BC06

ATC

capecitabine; oral

+∞

323.0

389

UJK02

NOMESCO Finland

ERCP

29.1

315.5

436

188

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

49.9

294.3

357

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

120.1

287.4

307

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

286.2

268

K83.1

ICD-10 Finland

Obstruction of bile duct

71.2

284.8

325

WX302

NOMESCO Finland

Thoracal epidural anesthesy

30.5

271.2

369

146

JN4BD

NOMESCO Finland

Extensive body CT

14.0

270.8

494

455

A04AA01

ATC

ondansetron; systemic, rectal

30.9

260.3

353

137

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

240.4

226

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

152.1

231.1

242

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

16.9

230.0

382

274

JN4CD

NOMESCO Finland

Very extensive body CT

28.0

222.0

309

129

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

212.2

200

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

40.4

209.0

265

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

947.5

180.0

174

JN4AD

NOMESCO Finland

Body CT examination

13.4

176.8

323

282

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

173.4

164

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

905.9

172.5

167

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

27.3

171.7

240

D76

ICPC

Malignant neoplasm pancreas

870.5

166.1

161

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.1

156.5

785

2693

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

22.2

142.1

211

105

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

29.7

137.2

187

R4190

NOMESCO Finland

Nutritional therapy

21.1

133.1

201

105

L03AA02

ATC

filgrastim; parenteral

284.6

131.8

133

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

128.5

122

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

19.3

127.1

198

113

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

8.5

122.7

285

381

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

121.0

115

A06AH03

ATC

naloxegol; oral

67.6

120.6

139

WZC30

NOMESCO Finland

Teaching

5.5

117.0

387

838

JLC10

NOMESCO Finland

Distal pancreatectomy

406.2

116.8

116

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

115.7

110

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

115.7

110

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

32.7

114.5

152

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

11.0

112.0

223

225

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

175.4

111.5

116

JN3BD

NOMESCO Finland

Extensive abdominal CT

5.0

111.3

396

927

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1115.1

109.5

106

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.7

108.1

338

680

C61

ICD-10 Finland

Malignant neoplasm of prostate

169.0

107.3

112

JAH01

NOMESCO Finland

Laparoscopy

10.7

106.6

215

222

L03AA13

ATC

pegfilgrastim; parenteral

1081.8

106.3

103

TPX10

NOMESCO Finland

Implantation of vascular injection port

13.9

106.1

188

148

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

143.7

103.1

109

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

1015.5

99.9

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

98.7

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

97.7

A04AA55

ATC

palonosetron, combinations; systemic

+∞

95.5

B01AB10

ATC

tinzaparin; parenteral

7.2

95.4

247

384

K83.0

ICD-10 Finland

Cholangitis

15.3

91.0

154

108

JDE00

NOMESCO Finland

Gastrojejunostomy

165.8

90.9

C25

ICD-10 Finland

Malignant neoplasm of pancreas

456.6

88.8

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

895.1

88.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

88.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.8

87.2

421

1297

B01AB05

ATC

enoxaparin; parenteral

2.8

86.7

752

3528

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

38.6

86.4

110

R18

ICD-10 Finland

Ascites

16.8

85.9

140

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

98.4

85.7

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

67.0

83.3

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

24.0

81.9

118

A04AD12

ATC

aprepitant; systemic

+∞

78.6

JMA10

NOMESCO Finland

Transabdominal total splenectomy

99.6

78.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

76.5

387

1228

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

140.4

76.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.5

76.2

244

495

WW500

NOMESCO Finland

Blood transfusion

9.2

75.6

164

191

R50.9

ICD-10 Finland

Fever, unspecified

3.4

74.8

411

1390

JN3AD

NOMESCO Finland

Abdominal CT examination

4.8

72.8

265

618

WF002

NOMESCO Finland

Radical radiotherapy

127.8

69.3

116

Kela drug reimbursment

Prostate cancer

+∞

69.1

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

66.0

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

66.0

WF049

NOMESCO Finland

Radiotherapy of metastasis

227.0

64.5

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.8

62.3

290

848

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

24.1

61.5

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

59.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

10.9

59.6

117

113

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

13.8

58.8

103

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

205.8

58.3

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

+∞

57.6

191

Kela drug reimbursment

Erlotinib

+∞

56.5

H01CB03

ATC

lanreotide; parenteral

198.7

56.3

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

91.3

56.2

J01MA12

ATC

levofloxacin; systemic

2.6

55.8

501

2287

L01AX03

ATC

temozolomide; systemic

+∞

55.4

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

55.4

A98

ICPC

Health maint/preventive medicine

0.5

54.7

1175

15217

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

54.5

516

2421

1CD01

NOMESCO Finland

+∞

53.3

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

+∞

53.3

A79

ICPC

Malignancy NOS

117.1

53.0

ZX120

NOMESCO Finland

Intravenous

3.7

53.0

250

735

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

+∞

52.3

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

33.4

52.0

JAH00

NOMESCO Finland

Laparotomy

7.3

51.4

128

185

XX3DW

NOMESCO Finland

Time consuming IT work

4.7

50.9

185

426

A10AE04

ATC

insulin glargine; parenteral

3.0

50.6

322

1183

115

Kela drug reimbursment

Breast cancer

+∞

50.2

8140/3-C25.1

ICD-O-3

Adenocarcinoma, NOS, of body of pancreas

+∞

49.1

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

48.8

284

979

N02AX02

ATC

tramadol; systemic, rectal

2.0

48.4

924

5913

A02BC02

ATC

pantoprazole; systemic

2.0

47.2

1317

9713

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

47.9

46.2

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

17.0

46.2

H01CB02

ATC

octreotide; parenteral

240.2

46.2

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

46.0

8010/3-C25.9

ICD-O-3

Carcinoma, NOS, of pancreas, NOS

+∞

44.9

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

33.1

44.3

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

156.7

43.9

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

40.3

43.9

L01XE03

ATC

[U] erlotinib; oral

+∞

42.8

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

22.8

42.8

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

425.9

42.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

42.1

699

4166

A06AD11

ATC

lactulose; oral

2.3

42.0

466

2330

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.9

41.5

107

163

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

214.1

41.0

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

40.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

40.7

358

1586

SPAT1109

SPAT

Analgesia with portable analgesic pump

25.4

40.7

WX004

NOMESCO Finland

Patient-controlled sedation

28.2

40.4

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

405.0

40.2

L02AE02

ATC

leuprorelin; implant, parenteral

67.1

40.2

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

11.1

39.9

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

39.7

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

39.7

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

39.7

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

39.7

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

58.7

39.4

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

7.4

39.0

133

1570A

ICD-9 Finland

Malignant neoplasm of pancreas, Head of pancreas

+∞

38.7

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

25.1

38.5

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

384.1

38.1

ZX122

NOMESCO Finland

Intra-arterial

22.6

36.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

36.1

485

2621

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

35.4

728

4629

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

35.1

642

3911

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

52.2

34.5

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

34.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

33.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

33.4

N02AA01

ATC

morphine; systemic, rectal

9.2

33.2

B01AB04

ATC

dalteparin; parenteral

3.8

33.1

150

422

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

32.5

351

1710

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

115.1

31.7

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

31.3

8000/3-C25.1

ICD-O-3

Neoplasm, malignant of body of pancreas

+∞

31.3

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

86.4

30.8

D70.82

ICD-10 Finland

Drug-induced neutropenia

29.8

30.8

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

30.3

WX402

NOMESCO Finland

General anaesthesia

2.5

30.0

250

1066

E34.0

ICD-10 Finland

Carcinoid syndrome

306.6

29.9

WF003

NOMESCO Finland

Adjuvant radiotherapy

108.3

29.7

K85.8

ICD-10 Finland

Other acute pancreatitis

18.1

29.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.3

29.2

ZX090

NOMESCO Finland

Other technic of radiotherapy

104.8

28.7

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

28.2

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

285.1

27.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.8

27.4

121

334

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

27.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

141.8

26.7

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

29.6

26.3

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

14.5

26.2

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

26.1

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

+∞

26.1

JLA00

NOMESCO Finland

Exploration of pancreas

263.7

25.7

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

25.0

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

39.3

24.9

K86.1

ICD-10 Finland

Other chronic pancreatitis

7.9

24.8

HAC20

NOMESCO Finland

Total mastectomy

91.2

24.7

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

16.5

24.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

24.4

382

2154

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

5.2

24.4

153

TJA10

NOMESCO Finland

Laparocentesis

87.8

23.7

SPAT1053

SPAT

Memory test

0.4

23.6

120

2662

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

23.6

155

572

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.5

23.5

295

4884

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.0

23.1

242

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

232.3

22.7

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

232.3

22.7

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

232.3

22.7

197

Kela drug reimbursment

Sunitinib

+∞

21.9

8000/3-C25.2

ICD-O-3

Neoplasm, malignant of tail of pancreas

+∞

21.9

158

Kela drug reimbursment

Everolimus

+∞

21.9

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

21.9

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

21.9

149

562

WX002

NOMESCO Finland

Sedation and analgesia

1.8

21.9

401

2383

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

63.2

21.9

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

29.4

21.9

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.6

21.8

392

5936

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

9.4

21.8

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.2

21.8

1163

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

81.0

21.7

JLA10

NOMESCO Finland

Biopsy of pancreas

81.0

21.7

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

81.0

21.7

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

222.1

21.6

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

222.1

21.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

222.1

21.6

P20

ICPC

Memory disturbance

0.4

21.5

2111

N06DX01

ATC

memantine; oral

0.2

21.1

1232

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

20.9

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

20.9

SAA01

NOMESCO Finland

Simple examination of mouth

0.6

20.6

662

8816

L02BB03

ATC

bicalutamide; oral

211.9

20.6

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.4

20.6

106

2347

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

111.1

20.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.5

20.1

230

3936

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

20.0

827

6166

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

19.8

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

19.8

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

74.2

19.7

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

24.8

19.5

C10AA07

ATC

rosuvastatin; oral

0.5

19.4

190

3405

K86.8

ICD-10 Finland

Other specified diseases of pancreas

15.0

18.9

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

18.8

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

18.8

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

18.8

I50.9

ICD-10 Finland

Heart failure, unspecified

0.5

18.7

156

2938

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

23.9

18.6

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

100.9

18.6

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

191.6

18.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

18.1

286

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

53.0

18.0

ZX121

NOMESCO Finland

Central venous catheter

26.9

17.8

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

17.8

571

3970

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

17.7

JLC00

NOMESCO Finland

Excision of lesion of pancreas

181.4

17.5

M25.5

ICD-10 Finland

Pain in joint

0.5

17.5

167

3027

N05AD01

ATC

haloperidol; systemic

2.9

17.4

106

373

TPX15

NOMESCO Finland

Removal of vascular injection port

24.2

17.3

H25.1

ICD-10 Finland

Senile nuclear cataract

0.6

17.3

319

4853

A41.8

ICD-10 Finland

Other specified sepsis

4.5

17.2

139

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.6

17.1

239

3896

WX610

NOMESCO Finland

Patient controlled analgesia

17.5

16.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

16.8

155

690

M79.6

ICD-10 Finland

Pain in limb

0.6

16.8

292

4510

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

16.7

1579X

ICD-9 Finland

Malignant neoplasm of pancreas, Pancreas, part unspecified

+∞

16.7

WX892

NOMESCO Finland

Monitored bed care

2.3

16.5

164

760

C10AA05

ATC

atorvastatin; oral

0.6

16.4

468

6482

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.4

16.3

2009

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

47.9

16.0

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

15.7

564

7478

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.6

15.6

354

5160

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

15.6

C50.99

ICD-10 Finland

Breast, unspecified

+∞

15.6

8249/3-C25.2

ICD-O-3

Neuroendocrine tumor, grade 2 of tail of pancreas

+∞

15.6

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

15.6

T73

ICPC

Neoplasm endocrine other/unspecified

85.7

15.6

J94.8

ICD-10 Finland

Other specified pleural conditions

4.9

15.6

103

KA1FN

NOMESCO Finland

Isotope renography

19.4

15.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

15.5

220

1184

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

161.1

15.5

V03AF03

ATC

calcium folinate; systemic

161.1

15.5

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

38.3

15.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

15.3

238

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

15.2

237

3772

R11

ICD-10 Finland

Nausea and vomiting

2.2

15.1

162

776

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.6

15.0

327

4813

K02.1

ICD-10 Finland

Caries of dentine

0.7

14.9

481

6530

K31.5

ICD-10 Finland

Obstruction of duodenum

31.9

14.8

Y77

ICPC

Malignant neoplasm prostate

57.1

14.8

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.6

14.7

311

4613

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

10.5

14.7

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

7.5

14.7

SFA10

NOMESCO Finland

Fillning on one surface of tooth

0.7

14.7

458

6264

JKA20

NOMESCO Finland

Cholecystectomy

3.0

14.7

297

8246/3-C25.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of pancreas, NOS

+∞

14.6

JKD00

NOMESCO Finland

Anastomosis of gallbladder to jejunum

+∞

14.6

340

Kela drug reimbursment

Everolimus

+∞

14.6

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

14.6

L01XE10

ATC

[U] everolimus; oral

+∞

14.6

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

14.6

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.0

14.5

293

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

150.9

14.5

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.1

14.4

L02BG04

ATC

letrozole; oral

17.1

14.3

E13

ICD-10 Finland

Other specified diabetes mellitus

27.4

14.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.7

14.2

426

5883

A10AE05

ATC

insulin detemir; parenteral

2.3

14.2

131

587

L03

ICPC

Low back symptom/complaint

0.5

13.9

151

2653

L15

ICPC

Knee symptom/complaint

0.5

13.8

131

2389

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.6

13.7

242

3745

B01AF02

ATC

apixaban; oral

0.4

13.6

1444

JN4DD

NOMESCO Finland

Scout CT scan of torso

75.6

13.6

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.5

13.6

179

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

13.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

13.6

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

+∞

13.6

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

13.6

WF001

NOMESCO Finland

Preoperative radiotherapy

140.8

13.5

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.4

13.3

1552

N06DA02

ATC

donepezil; oral

0.3

13.3

1026

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.3

13.2

DAX08

NOMESCO Finland

Fitting of hearing aid

0.2

13.1

581

A10BA02

ATC

metformin; oral

1.5

13.1

627

4714

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

15.1

13.1

WX320

NOMESCO Finland

Spinalanesthesy

0.6

13.0

177

2927

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.8

13.0

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

50.3

12.8

Z01.2

ICD-10 Finland

Dental examination

0.6

12.8

299

4365

Z31.5

ICD-10 Finland

Genetic counselling

3.7

12.8

156

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

12.8

397

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

7.2

12.8

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

12.7

481

3437

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

70.3

12.6

JFC00

NOMESCO Finland

Entero-enterostomy

32.2

12.6

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

12.5

L01XE04

ATC

[U] sunitinib; oral

+∞

12.5

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

12.5

C90.0

ICD-10 Finland

Multiple myeloma

+∞

12.5

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

12.5

1571A

ICD-9 Finland

Malignant neoplasm of pancreas, Body of pancreas

+∞

12.5

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

12.5

EB1AA

NOMESCO Finland

Tooth X-ray examination

0.7

12.5

503

6607

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

20.1

12.4

207

Kela drug reimbursment

Chronic arrhythmias

0.6

12.3

150

2555

SDA02

NOMESCO Finland

Parodonthologic therapy

0.6

12.3

222

3430

ZX112

NOMESCO Finland

Subcutaneous

7.5

12.2

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.0

12.2

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.2

12.1

568

J01MA02

ATC

ciprofloxacin; systemic

1.4

12.0

718

5619

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

0.7

12.0

430

5779

R03AC02

ATC

salbutamol; inhalant

0.7

12.0

557

7150

R83

ICPC

Respiratory infection other

0.5

12.0

1547

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.0

12.0

120

N07BC02

ATC

methadone; systemic

46.9

11.9

E16.10

ICD-10 Finland

Hyperinsulinism

65.3

11.6

D13

ICPC

Jaundice

65.3

11.6

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

19.0

11.6

L02BA01

ATC

tamoxifen; oral

23.0

11.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.5

11.5

B01AC04

ATC

clopidogrel; oral

0.6

11.5

176

2834

L08

ICPC

Shoulder symptom/complaint

0.5

11.5

131

2274

I81

ICD-10 Finland

Portal vein thrombosis

10.1

11.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

11.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

11.5

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

11.5

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

11.5

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

+∞

11.5

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

11.5

L01BC04

ATC

carmofur; oral

+∞

11.5

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

11.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

11.5

8240/3-C25.2

ICD-O-3

Neuroendocrine tumor, NOS, of tail of pancreas

+∞

11.5

ZX080

NOMESCO Finland

Image guided radiotherapy

120.6

11.4

WW200

SPAT

0.3

11.4

915

K56.7

ICD-10 Finland

Ileus, unspecified

3.9

11.3

117

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

11.2

218

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.5

11.2

100

1858

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

12.8

11.1

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.6

11.1

178

2835

K86.3

ICD-10 Finland

Pseudocyst of pancreas

7.1

11.0

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.5

11.0

1627

HAB40

NOMESCO Finland

Wedge excision of mammary gland

10.1

11.0

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.3

11.0

716

T90

ICPC

Diabetes non-insulin dependent

1.5

10.9

463

3376

N06DA03

ATC

rivastigmine; oral, transdermal

0.3

10.8

658

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

10.7

102

463

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

28.2

10.7

L13

ICPC

Hip symptom/complaint

0.5

10.7

109

1951

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.8

10.7

118

G04BD12

ATC

mirabegron; oral

0.4

10.5

1231

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.2

10.4

441

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.3

10.4

798

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

10.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

10.4

325

Kela drug reimbursment

Erlotinib

+∞

10.4

D77

ICPC

Malignant digestive neopl other/NOS

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

10.4

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

10.4

R5140

NOMESCO Finland

Monitoring the use of the aid

0.4

10.4

1185

XF612

NOMESCO Finland

Measurement of central venous pressure

12.1

10.3

WX882

NOMESCO Finland

High dependency care

3.0

10.3

201

HA1AA

NOMESCO Finland

X-ray mammography

3.2

10.2

166

H26.4

ICD-10 Finland

After-cataract

0.5

10.1

1381

F03

ICD-10 Finland

Unspecified dementia

0.4

10.1

938

NK6AN

NOMESCO Finland

Total body bone isotope imaging

10.1

10.0

A21

ICPC

Risk factor for malignancy

40.2

10.0

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

40.2

10.0

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.9

356

2501

DFF00

NOMESCO Finland

Pure tone audiometry

0.4

9.8

1048

L17

ICPC

Foot/toe symptom/complaint

0.6

9.7

217

3214

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

9.7

112

557

R4110

NOMESCO Finland

Physiotherapy

1.5

9.7

424

3103

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

7.8

9.6

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.4

9.6

949

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.6

9.6

118

2012

D70.89

ICD-10 Finland

Neutropenic splenomegaly

6.4

9.5

N02AA03

ATC

hydromorphone; systemic, rectal

15.1

9.5

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.6

9.5

194

2930

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

9.4

989

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

9.4

148

N05AX08

ATC

risperidone; systemic

0.5

9.4

1159

N05CF01

ATC

zopiclone; oral

1.4

9.4

615

4848

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

9.4

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

9.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

9.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

9.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

9.4

PHN72

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

9.4

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

9.4

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

9.4

322

Kela drug reimbursment

Sunitinib

+∞

9.4

6706

FHL

Pancreatic homeectomy (eg Whipple)

+∞

9.4

8480/3-C25.9

ICD-O-3

Mucinous adenocarcinoma of pancreas, NOS

+∞

9.4

1572A

ICD-9 Finland

Malignant neoplasm of pancreas, Tail of pancreas

+∞

9.4

8010/3-C25.0

ICD-O-3

Carcinoma, NOS, of head of pancreas

+∞

9.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

9.4

L01CB01

ATC

etoposide; systemic

+∞

9.4

PHC71

NOMESCO Finland

Suture of mesenteric or portal vein

+∞

9.4

K85

ICD-10 Finland

Acute pancreatitis

3.2

9.4

154

C10AX09

ATC

ezetimibe; oral

0.5

9.4

1391

UJK12

NOMESCO Finland

Peroral cholangioscopy

12.4

9.4

H81

ICPC

Excessive ear wax

0.6

9.3

141

2282

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

9.3

285

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

5.7

9.2

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.5

9.2

1356

I50.1

ICD-10 Finland

Left ventricular failure

0.4

9.1

886

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.3

9.1

638

WX704

NOMESCO Finland

Intubation

2.1

9.0

103

512

SPAT1255

SPAT

Intravenous administration of medicine

2.0

9.0

119

623

I50.0

ICD-10 Finland

Congestive heart failure

0.5

9.0

1502

WX600

NOMESCO Finland

Single shot through catheter

7.5

8.9

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

0.7

8.8

355

4723

SPAT1088

SPAT

Blood transfusion

10.7

8.8

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

10.7

8.8

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

8.7

938

10804

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

50.2

8.7

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

50.2

8.7

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

8.6

136

Z96.1

ICD-10 Finland

Presence of intraocular lens

0.6

8.6

134

2157

R42

ICD-10 Finland

Dizziness and giddiness

0.7

8.6

225

3233

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

8.5

286

3925

D13.9

ICD-10 Finland

Benign neoplasm: Ill-defined sites within the digestive system

20.1

8.5

C50

ICD-10 Finland

Malignant neoplasm of breast

90.4

8.4

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.9

8.4

H02

ICPC

Hearing complaint

0.6

8.4

1655

H25.8

ICD-10 Finland

Other senile cataract

0.6

8.4

110

1842

R06AX27

ATC

desloratadine; oral

0.6

8.3

147

2300

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

8.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

8.3

8249/3-C25.0

ICD-O-3

Neuroendocrine tumor, grade 2 of head of pancreas

+∞

8.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

8.3

8500/3-C25.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of body of pancreas

+∞

8.3

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

8.3

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

8.3

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.3

8.3

610

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

8.3

324

C10AC01

ATC

colestyramine; oral

2.7

8.2

199

D19

ICPC

Teeth/gum symptom/complaint

0.6

8.2

164

2493

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.6

8.1

100

1703

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

8.1

309

4152

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.5

8.1

1365

K86.2

ICD-10 Finland

Cyst of pancreas

4.9

8.1

AA1AD

NOMESCO Finland

CT of head and brain

0.7

8.0

270

3712

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

8.0

198

2879

CJB10

NOMESCO Finland

Laser discission of secondary cataract

0.5

7.9

1174

SPAT1290

SPAT

Preparation of deceased person

13.1

7.9

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

13.1

7.9

R96

ICPC

Asthma

0.4

7.9

896

L30.9

ICD-10 Finland

Dermatitis, unspecified

0.6

7.8

110

1813

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.7

7.8

529

6514

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

0.4

7.8

744

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

9.4

7.8

EBA00

NOMESCO Finland

Extraction of tooth

0.7

7.8

284

3845

I48

ICD-10 Finland

Atrial fibrillation and flutter

0.7

7.8

356

4647

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

7.7

305

4082

F51.0

ICD-10 Finland

Nonorganic insomnia

0.5

7.7

1029

L02BG03

ATC

anastrozole; oral

45.1

7.7

SPAT1043

SPAT

Audiometry

0.5

7.7

1398

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

7.7

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

7.6

1000

R74

ICPC

Upper respiratory infection acute

0.6

7.6

140

2171

R10.0

ICD-10 Finland

Acute abdomen

2.5

7.6

224

M01AH05

ATC

etoricoxib; oral

0.8

7.6

612

7371

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

25.1

7.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

7.6

325

DFF15

NOMESCO Finland

Speech audiometry

0.3

7.5

519

T89

ICPC

Diabetes insulin dependent

2.4

7.5

246

SPAT1269

SPAT

Other puncture and/or drainage

6.2

7.5

WX290

NOMESCO Finland

Other blockade of nerve

0.7

7.5

307

4084

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

7.4

1653

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

80.3

7.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

80.3

7.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

80.3

7.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

80.3

7.4

BBA50

NOMESCO Finland

Total parathyroidectomy

80.3

7.4

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

80.3

7.4

SPAT1110

SPAT

Measurement of pain intensity

5.0

7.4

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.5

7.4

1357

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

7.4

H25.0

ICD-10 Finland

Senile incipient cataract

0.4

7.3

830

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

7.3

JLA20

NOMESCO Finland

Needle biopsy of pancreas

+∞

7.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

7.3

8500/3-C25.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of tail of pancreas

+∞

7.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

7.3

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

+∞

7.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

7.3

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

7.3

L02BX02

ATC

degarelix; parenteral

+∞

7.3

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

7.3

V03AH01

ATC

diazoxide; systemic

+∞

7.3

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

7.3

1BC05

NOMESCO Finland

+∞

7.3

8249/3-C25.1

ICD-O-3

Neuroendocrine tumor, grade 2 of body of pancreas

+∞

7.3

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

JN7SN

NOMESCO Finland

Somatostatin receptor SPECT

+∞

7.3

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

+∞

7.3

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

7.2

343

ZZR00

NOMESCO Finland

Flap of skin

5.4

7.2

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.4

7.2

794

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.5

7.2

1030

RD210

NOMESCO Finland

3.7

7.2

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

20.1

7.1

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

20.1

7.1

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.9

7.1

134

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

0.7

7.1

170

2489

K75.0

ICD-10 Finland

Abscess of liver

12.1

7.1

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

12.1

7.1

R05

ICD-10 Finland

Cough

0.6

7.1

143

2170

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

7.1

164

2422

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

5.6

7.1

R05

ICPC

Cough

0.7

7.0

165

2428

Z97.4

ICD-10 Finland

Presence of external hearing-aid

0.4

7.0

703

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

10.0

7.0

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.1

7.0

259

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

0.5

7.0

1036

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.7

7.0

213

2981

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

0.5

7.0

1222

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

7.0

153

M54.5

ICD-10 Finland

Low back pain

0.7

6.9

284

3782

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

6.9

174

1121

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.2

6.9

R06.0

ICD-10 Finland

Dyspnoea

0.7

6.9

269

3611

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.6

6.9

1335

M48.0

ICD-10 Finland

Spinal stenosis

0.6

6.9

109

1748

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

13.8

6.9

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

3.7

6.9

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

8.3

6.8

ZYC01

SPAT

0.3

6.8

405

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

6.8

301

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

40.2

6.8

6672

FHL

Cholecocenterostomy

40.2

6.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

40.2

6.8

K31.0

ICD-10 Finland

Acute dilatation of stomach

16.7

6.7

G47.3

ICD-10 Finland

Sleep apnoea

0.7

6.7

173

2500

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.5

6.7

994

H29

ICPC

Ear symptom/complaint other

0.5

6.7

1205

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

22.6

6.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

22.6

6.7

D82

ICPC

Teeth/gum disease

0.7

6.6

255

3434

WX111

NOMESCO Finland

Local infiltration anesthesia

0.2

6.6

326

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.9

6.6

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.0

6.6

118

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

6.5

148

928

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.5

6.5

1001

I25.2

ICD-10 Finland

Old myocardial infarction

0.6

6.5

1417

L90

ICPC

Osteoarthrosis of knee

0.4

6.5

669

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

10.0

6.5

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.4

6.5

637

L12

ICPC

Hand/finger symptom/complaint

0.6

6.5

1377

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

0.7

6.5

365

4635

A04AA03

ATC

tropisetron; systemic

70.0

6.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

70.0

6.4

JJB10

NOMESCO Finland

Atypcal resection of liver

70.0

6.4

N05BA04

ATC

oxazepam; oral

1.4

6.4

402

3120

JN6AD

NOMESCO Finland

CT of torso and neck

7.4

6.4

UJD02

NOMESCO Finland

Gastroscopy

1.8

6.4

525

KMAK

NOMESCO Finland

0.8

6.4

487

5939

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.2

6.3

W19

ICD-10 Finland

Unspecified fall

0.5

6.3

1159

K92.0

ICD-10 Finland

Haematemesis

2.3

6.3

246

SPAT1097

SPAT

Recording of ECG

0.6

6.3

140

2082

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.9

6.3

125

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

9.3

6.3

NK6LA

NOMESCO Finland

Bone and joint kinetic X-ray examination

18.1

6.3

G03HA01

ATC

cyproterone; systemic

18.1

6.3

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

18.1

6.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

6.2

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

6.2

8246/3-C25.2

ICD-O-3

Neuroendocrine carcinoma, NOS, of tail of pancreas

+∞

6.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

6.2

8000/3-C25.8

ICD-O-3

Neoplasm, malignant of overlapping lesion of pancreas

+∞

6.2

XW2BT

NOMESCO Finland

Other cytological test with X-ray guidance

+∞

6.2

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

6.2

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.2

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

+∞

6.2

8151/3-C25.9

ICD-O-3

Insulinoma, NOS, of pancreas, NOS

+∞

6.2

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

6.2

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

6.2

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

6.2

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

6.2

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

6.2

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

6.2

18699

ICD-8 Finland

Malignant neoplasm of testis

+∞

6.2

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

6.2

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

6.2

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

6.2

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

26.7

6.2

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

7.0

6.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

6.2

231

3130

R50.8

ICD-10 Finland

Other specified fever

7.7

6.1

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

7.7

6.1

L01

ICPC

Neck symptom/complaint

0.6

6.1

1302

XCW99

NOMESCO Finland

Other investigative procedure of eye

0.6

6.1

1366

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.2

6.1

257

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

6.1

1289

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

0.4

6.0

688

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

10.0

6.0

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

6.0

470

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1778

7568

4.00

307.65

5.8

2.3

u/l

55.6

59.7

1.09

1677

6925

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

168

177.15

307.65

3.9

2.4

pmol/l

88.5

88.1

—

142

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1013

2336

5.86

307.65

5.4

2.2

umol/l

37.9

8.1

37.95

950

2000

(3000570) Elastase.pancreatic [Mass/mass] in Stool

896

651

18.66

307.65

1.6

1.4

ug/g

154.8

288.2

36.60

532

393

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1087

490

32.91

307.65

6.6

1.8

u/ml

14053.2

88.9

1.78

996

388

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1734

1365

26.24

307.65

6.0

1.4

ug/l

62.4

3.7

2.70

1618

1023

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

985

1853

7.21

307.65

3.6

1.9

g/l

0.2

1.60

938

1664

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

797

270

38.85

307.65

6.3

1.8

u/ml

4218.8

80.3

6.08

746

244

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

367

127

32.47

307.65

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

577

104

67.32

307.65

4.7

1.8

nmol/l

16.7

4.8

0.68

571

(4035726)

546

679

9.47

307.65

1.4

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

762

1954

4.79

279.01

7.3

2.2

u/l

103.5

38.2

0.85

681

1632

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2156

11737

3.51

248.86

22.7

3.8

umol/l

23.7

12.3

26.12

2096

10914

(3024561) Albumin [Mass/volume] in Serum or Plasma

1920

10449

3.06

207.47

11.2

3.7

g/l

31.4

35.1

121.62

1855

9471

(40768441) Liver Pathology biopsy report

158

20.21

204.50

1.0

1.4

—

(3023368) Bacteria identified in Blood by Culture

1478

7046

3.02

201.71

6.5

3.9

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

194

340.25

193.68

2.9

4.3

u/l

721.3

779.3

—

175

(3010370) Gastrin [Moles/volume] in Serum or Plasma

39.12

155.04

2.7

1.3

pmol/l

32.8

25.7

0.50

(3032080) INR in Blood by Coagulation assay

1829

10736

2.62

153.79

10.7

11.1

inr

1.3

1.4

0.96

467

2913

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1331

6830

2.61

146.27

6.3

2.6

u/l

64.0

37.3

11.10

1280

6385

(3014576) Chloride [Moles/volume] in Serum or Plasma

794

3184

2.98

140.20

8.8

5.9

mmol/l

103.8

104.2

1.58

785

3107

(3033658) Prothrombin time (PT) actual/Normal

1145

5563

2.64

139.51

6.8

3.6

78.1

83.8

12.74

1124

5410

(3044640) Blood type and Crossmatch panel - Blood

1297

6762

2.53

135.53

3.3

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

848

3597

2.84

134.31

3.3

2.4

mmol/l

0.8

2.44

804

3275

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1645

10104

2.28

112.41

5.5

3.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1880

12620

2.17

97.82

23.7

6.0

e9/l

4.5

4.4

0.88

1693

10766

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

916

4640

2.36

95.82

8.3

2.2

mmol/l

2.5

17.40

871

3942

(3042936) Bacteria identified in Isolate by Culture

733

3362

2.53

95.51

2.1

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

980

5199

2.27

91.23

3.0

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1304

7885

2.10

85.89

8.9

2.1

mmol/l

2.3

2.4

12.42

1227

6459

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1799

23218

0.49

81.22

3.9

4.8

mmol/l

1.4

13.22

1560

20954

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1902

24084

0.49

80.78

4.3

5.4

mmol/l

2.5

2.6

3.97

1653

21802

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1828

23449

0.49

80.57

3.9

4.8

mmol/l

4.3

4.5

5.78

1598

21330

(3002256) Pathology report gross observation

431

1695

2.78

75.34

1.5

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

153

299

5.32

74.44

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

648

3184

2.29

70.11

3.4

5.1

mmol/l

1.0

4.77

612

2891

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

424

1721

2.68

69.41

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

302

1051

3.07

65.66

2.3

1.7

ug/l

1.9

1.7

0.13

277

891

(3024980) IgG subclass 4 [Mass/volume] in Serum

146

306

4.95

65.52

1.8

g/l

0.8

1.0

0.81

107

234

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1773

22464

0.53

64.23

3.7

4.3

mmol/l

1.3

3.16

1531

20069

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

258

845

3.23

62.10

2.4

3.0

u/ml

0.3

0.80

137

497

(3023183) Ammonium ion [Moles/volume] in Plasma

184

502

3.83

58.62

1.7

2.5

umol/l

38.8

35.9

0.49

144

421

(40758558) Short blood count panel - Blood

897

5301

1.96

58.26

18.2

4.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

180

493

3.81

57.01

1.5

1.4

nmol/l

0.7

0.8

2.67

163

403

(3023436) Glucagon [Mass/volume] in Serum or Plasma

124.32

57.00

2.0

1.0

ng/l

196.1

228.2

—

(40768804) Tissue Pathology biopsy report

1110

7160

1.84

54.26

2.6

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

371

1596

2.50

53.24

7.9

7.8

94.8

93.3

5.53

371

1589

(3003694) ABO and Rh group [Type] in Blood

880

5318

1.90

52.57

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1749

21816

0.57

52.27

4.2

4.6

mu/l

2.1

0.11

1521

19498

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1706

12577

1.75

52.22

8.6

5.6

mmol/l

1.2

15.88

1438

10500

(3013826) Glucose [Moles/volume] in Serum or Plasma

1931

14760

1.77

51.92

7.8

4.4

mmol/l

7.9

6.9

43.17

1864

13762

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1953

23623

0.56

51.80

4.9

5.1

mmol/l

6.7

6.1

37.67

1733

21116

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1576

11378

1.75

51.79

7.7

5.2

mmol/l

1.2

17.65

1491

10026

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

746

4339

1.94

49.64

2.0

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

9.37

49.27

1.4

2.6

e6/l

8146.9

732.4

0.59

(3018677) aPTT in Platelet poor plasma by Coagulation assay

695

3960

1.96

49.08

2.1

1.9

30.4

30.0

0.61

681

3824

(3002173) Hemoglobin [Mass/volume] in Arterial blood

492

2485

2.16

48.25

8.5

6.8

g/l

114.3

121.5

13.78

476

2392

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

114

256

4.58

47.03

1.4

1.2

nmol/l

1.2

1.5

2.81

100

227

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

343

1552

2.35

43.69

1.7

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1100

7458

1.72

43.03

3.3

3.1

e6/l

38.3

84.2

2.08

876

5690

(3018418) pH of Serum or Plasma

1075

7291

1.71

41.71

5.6

3.2

7.4

0.63

233

1274

(3016502) Oxygen saturation in Arterial blood

512

2766

2.01

41.48

8.2

6.4

96.7

95.0

8.48

499

2651

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

332

6516

0.45

41.21

1.6

mmol/l

1.4

1.3

0.36

296

5406

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

545

3018

1.97

41.11

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

546

3028

1.97

41.00

1.9

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

170

558

3.16

40.56

2.2

1.6

u/ml

178.6

30.0

3.98

162

530

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2218

18210

1.69

40.49

24.5

5.4

u/l

180.5

77.3

109.45

2160

16744

(3026782) Osmolality of Urine

775

4852

1.79

39.58

2.8

2.7

mosm/kgh2o

543.8

549.3

0.28

698

4040

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

8.87

39.31

1.3

2.4

e6/l

14125.4

39341.4

0.33

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

12.81

39.19

1.3

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1004

6785

1.70

38.91

3.2

3.0

e6/l

0.7

0.5

1.62

796

5089

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

295

1318

2.36

38.52

9.9

8.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

2285

25983

0.59

37.84

51.4

21.3

g/l

120.3

135.0

307.65

2233

25391

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

115

307

3.85

37.74

5.9

6.2

mg/l

11.7

12.4

0.92

102

278

(3007461) Platelets [#/volume] in Blood

2284

25970

0.59

37.72

51.1

21.1

e9/l

255.4

240.9

13.57

2209

25037

(3026361) Erythrocytes [#/volume] in Blood

2285

25977

0.59

37.68

51.0

21.1

e12/l

4.1

4.5

220.50

2202

24933

(3035941) MCH [Entitic mass]

2285

25975

0.59

37.63

50.8

21.0

30.2

30.5

11.07

2230

25380

(3024731) MCV [Entitic volume]

2285

25974

0.59

37.60

50.9

21.1

91.4

91.6

2.03

2231

25378

(3010813) Leukocytes [#/volume] in Blood

2286

25980

0.59

37.53

51.0

21.1

e9/l

7.6

6.8

32.93

2200

24941

(3003396) Base excess in Arterial blood by calculation

533

3032

1.91

36.79

8.1

6.2

mmol/l

1.0

1.2

0.68

455

2310

(4281824)

115

5.84

36.30

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

8.21

35.47

1.4

1.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

532

3059

1.88

35.42

8.1

6.2

kpa

5.1

0.02

516

2902

(3027801) Oxygen [Partial pressure] in Arterial blood

532

3059

1.88

35.42

8.1

6.2

kpa

14.0

11.5

19.64

517

2896

(3000991) Gas panel - Venous blood

399

2095

2.03

34.62

6.8

6.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

580

3453

1.83

34.49

2.1

2.6

18.9

22.3

6.26

495

2875

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1409

17754

0.63

34.08

3.6

3.8

pmol/l

15.0

0.13

1231

15790

(3004789) Transferrin [Mass/volume] in Serum or Plasma

608

3692

1.80

33.80

2.0

2.5

g/l

2.2

2.3

1.42

578

3381

(3014111) Lactate [Moles/volume] in Serum or Plasma

419

2262

1.98

33.56

6.0

5.8

mmol/l

1.5

1.4

0.49

410

2165

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1946

22814

0.63

33.56

7.8

6.6

mmol/mol

45.2

41.0

40.97

1783

20781

(36304419) Bacteria [Presence] in Urine

946

6516

1.64

32.98

3.2

3.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

645

4038

1.75

32.10

2.1

2.5

umol/l

10.2

12.6

14.03

621

3675

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

173

661

2.71

31.33

1.9

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

150

550

2.81

29.39

1.9

2.3

g/l

3.2

3.5

2.58

144

523

(3021447) Carbon dioxide [Partial pressure] in Venous blood

450

2593

1.85

29.37

3.3

kpa

5.6

5.8

6.21

437

2497

(3027923) C peptide [Moles/volume] in Serum or Plasma

144

4.73

29.20

1.3

nmol/l

0.9

1.3

2.59

104

(3018095) Leukocytes [#/volume] in Urine

1163

8605

1.55

29.10

3.7

3.5

e6/l

65.6

113.5

2.86

901

6121

(3002032) Base excess in Venous blood by calculation

448

2587

1.85

29.02

3.3

mmol/l

2.0

0.00

373

2078

(3012544) pH of Venous blood

458

2701

1.81

27.62

3.4

3.3

—

7.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

402

2289

1.86

27.13

4.0

6.5

mmol/l

8.5

11.5

12.87

377

2151

(3044007) Cell count panel - Peritoneal fluid

7.53

26.74

1.2

2.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

105

344

3.12

25.16

1.1

iu/ml

28.3

65.8

0.49

(42870588) Differential panel, method unspecified - Blood

1042

7741

1.51

24.59

5.2

5.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1919

22079

0.68

24.25

35.8

13.5

ml/min/173m2

80.9

73.5

44.60

1720

17786

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

583

3819

1.64

23.75

3.0

2.9

e6/l

3.3

2.4

1.04

320

2082

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1694

13917

1.46

23.69

5.4

3.0

u/l

223.4

50.5

62.03

1608

12583

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2258

25105

0.67

22.95

27.4

9.4

u/l

40.8

25.2

61.70

2202

23850

(3024354) Oxygen [Partial pressure] in Venous blood

372

2178

1.80

22.76

2.9

kpa

4.5

0.10

360

2088

(3023103) Potassium [Moles/volume] in Serum or Plasma

2273

25215

0.67

22.49

39.6

17.8

mmol/l

3.9

4.0

16.42

2215

24406

(3000850) Epithelial cells [#/volume] in Urine

742

5222

1.55

22.12

2.6

2.5

e6/l

6.8

4.9

2.52

667

4508

(3008152) Bicarbonate [Moles/volume] in Arterial blood

318

1799

1.85

21.73

9.3

6.3

mmol/l

24.3

24.5

0.23

304

1675

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

302

3.07

21.37

2.5

5.3

iu/ml

3052.7

508.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2273

25156

0.68

21.37

39.7

17.7

mmol/l

137.9

139.7

132.16

2216

24388

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

294

1636

1.88

21.14

2.0

1.7

—

(4062490)

187

3.64

20.71

1.6

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

124

499

2.54

20.27

2.0

2.1

238.5

194.9

4.73

113

477

(3027135) IgG subclass 1 [Mass/volume] in Serum

187

3.53

19.23

1.6

1.4

g/l

6.9

7.0

0.05

131

(3028192) IgG subclass 2 [Mass/volume] in Serum

187

3.53

19.23

1.6

1.4

g/l

3.1

3.0

0.24

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

187

3.53

19.23

1.6

1.4

g/l

0.4

0.21

130

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

604

8416

0.65

19.19

3.9

3.8

21.1

24.4

6.14

279

4173

(3020891) Body temperature

222

1167

1.97

18.91

5.7

4.6

—

(40761511) CBC panel - Blood by Automated count

2193

24267

0.70

18.48

31.2

14.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

118

490

2.46

18.08

1.3

—

(1761868) Lipid panel - Serum or Plasma

484

6991

0.64

17.98

3.0

3.3

—

(3019060) Gas panel - Arterial blood

314

1882

1.74

17.58

6.8

4.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

625

8527

0.67

17.53

1.9

2.2

u/l

188.3

218.8

0.46

569

7937

(3019069) Monocytes/100 leukocytes in Blood

1308

10639

1.39

17.28

5.6

5.8

8.6

8.9

1.76

1243

9756

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

472

2.44

17.11

1.3

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

590

4151

1.52

17.10

2.9

2.7

e6/l

1.4

1.3

0.27

325

2402

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

157

764

2.11

16.54

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

1323

10835

1.37

16.53

5.6

5.7

22.2

26.4

31.93

1246

9875

(3006504) Eosinophils/100 leukocytes in Blood

1296

10589

1.37

16.38

5.4

5.5

2.4

3.0

18.72

1230

9669

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.47

16.10

1.3

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

274

1623

1.75

15.96

1.3

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

293

2.77

15.82

2.5

3.0

1.1

1.4

0.33

217

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

813

10404

0.71

15.57

4.1

3.9

ug/l

2.7

2.6

0.03

683

9251

(40768797) Stomach Pathology biopsy report

475

3250

1.54

15.56

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

296

2.75

15.52

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1850

16072

1.35

15.35

4.7

e6/l

301.6

2818.8

3.29

266

(3022096) Basophils/100 leukocytes in Blood

1255

10298

1.36

15.06

5.4

5.5

0.6

0.7

6.12

1191

9419

(3027273) Bicarbonate [Moles/volume] in Venous blood

250

1469

1.76

14.97

3.6

3.0

mmol/l

24.8

25.2

0.92

242

1414

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

210

1171

1.85

14.96

7.8

4.3

1.7

1.6

0.34

196

1100

(40768795) Lymph node Pathology biopsy report

5.78

14.92

1.4

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

352

2.54

14.65

1.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

378

2.48

14.48

2.9

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.69

14.46

3.0

2.5

—

(3018010) Neutrophils/100 leukocytes in Blood

1294

10722

1.34

14.36

5.4

5.5

61.7

58.4

14.49

1226

9830

(3007930) Methemoglobin/Hemoglobin.total in Blood

204

1152

1.82

13.96

8.0

4.4

0.9

0.24

191

1083

(3016650) Hepatitis A virus Ab [Presence] in Serum

284

2.68

13.95

1.0

—

(3036489) Thrombin time

146

738

2.02

13.92

1.8

23.1

21.2

2.04

136

662

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

213

3538

0.57

13.72

1.2

u/ml

8.1

16.3

1.19

1287

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

279

1738

1.66

13.48

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

410

5820

0.66

13.41

2.9

2.8

ug/l

0.8

0.7

0.30

276

4047

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

3.69

13.18

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

209

1210

1.78

13.17

2.9

3.6

mmol/l

24.4

24.2

0.31

195

1057

(3012501) Base excess in Blood by calculation

118

563

2.14

13.14

5.5

4.6

mmol/l

2.9

2.7

0.25

372

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

220

1295

1.75

13.09

9.1

8.0

mmol/l

24.3

24.4

0.10

214

1175

(3039000) Anion gap in Blood

120

578

2.12

13.04

10.7

6.0

mmol/l

10.7

11.3

1.37

109

518

(3018572) Chloride [Moles/volume] in Blood

120

578

2.12

13.04

10.7

6.0

mmol/l

105.9

105.0

1.37

109

518

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

6.49

12.36

2.6

1.0

u/l

112.2

37.5

—

(3051651) Icteric interference index of Serum or Plasma

113

3.57

12.26

5.3

4.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

238

3735

0.61

12.17

1.2

1.3

iu/ml

41.3

41.2

0.00

1142

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

26.78

12.04

1.1

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

158

867

1.86

11.88

4.9

4.1

mmol/l

3.9

0.06

150

814

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

156

3.11

11.82

1.1

1.2

mmol/l

11.3

11.6

0.11

(3047181) Lactate [Moles/volume] in Blood

151

820

1.88

11.73

9.7

5.5

mmol/l

1.5

1.3

1.24

135

723

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

304

2023

1.55

11.16

5.8

3.0

mmol/l

1.2

1.35

287

1709

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

106

3.52

11.13

1.1

—

(3001604) Monocytes [#/volume] in Blood

1332

11362

1.29

11.08

5.4

5.2

e9/l

0.6

0.94

1113

9651

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

373

2598

1.49

11.06

3.4

2.8

u/l

261.5

239.5

1.23

357

2399

(3010421) pH of Blood

126

658

1.95

11.02

5.4

4.5

7.4

0.42

116

549

(3006315) Basophils [#/volume] in Blood

1339

11446

1.29

10.90

5.4

5.2

e9/l

0.0

1.92

1123

9738

(3022475) Manganese [Moles/volume] in Blood

28.11

10.72

1.2

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

307

2.38

10.55

1.3

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

1356

11645

1.28

10.53

5.5

5.3

e9/l

1.6

1.8

7.36

1166

10049

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

799

0.25

10.49

1.8

1.5

—

(3003338) MCHC [Mass/volume]

1727

19219

0.78

10.46

46.5

19.1

g/l

329.9

331.9

16.78

1692

19004

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

106

3.42

10.41

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

182

2.77

10.12

2.1

1.4

—

(3026008) Bacteria identified in Urine by Culture

951

7863

1.30

9.74

3.0

3.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1605

17930

0.79

9.58

3.5

4.2

mm/h

18.2

13.2

20.79

1459

16367

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

218

3301

0.64

9.43

3.7

4.9

32.8

33.3

0.21

133

2121

(3026493) Urate [Moles/volume] in Serum or Plasma

524

6742

0.73

9.31

2.7

2.5

umol/l

3293.1

6714.4

1.14

428

5646

(3008037) Lactate [Moles/volume] in Venous blood

124

690

1.83

8.99

4.0

3.1

mmol/l

1.6

1.7

0.22

124

670

(3038177) Helicobacter pylori Ab [Presence] in Serum

279

2.32

8.97

1.3

—

(3013115) Eosinophils [#/volume] in Blood

1358

11825

1.26

8.90

5.5

5.3

e9/l

0.2

6.58

1159

10189

(3038515) Glucose [Moles/volume] in Venous blood

119

656

1.85

8.89

4.2

3.2

mmol/l

8.6

7.9

1.49

119

636

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

231

2.45

8.87

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

315

2.22

8.69

1.3

1.5

g/l

35.9

27.7

3.55

278

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

361

2.13

8.68

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

102

540

1.92

8.64

1.2

titre

98.6

91.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

141

2.86

8.63

1.3

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

278

2.29

8.60

1.2

1.5

e6/l

2692.0

1471.8

0.79

203

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1238

0.45

8.52

1.8

1.9

—

(3025941) Bacteria identified in Stool by Culture

181

1137

1.63

8.51

1.3

—

(44790047)

224

2.43

8.47

1.3

1.4

—

(44806118)

224

2.43

8.47

1.3

1.4

—

(44790048)

224

2.43

8.47

1.3

1.4

—

(44790049)

224

2.43

8.47

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

355

2581

1.42

8.36

5.3

3.4

—

(3017181) Myelocytes/100 leukocytes in Blood

268

1852

1.49

8.24

2.7

3.8

1.1

0.9

0.83

132

401

(3009542) Hematocrit [Volume Fraction] of Blood

1878

20441

0.81

8.03

36.4

16.0

35.2

39.0

39.14

1178

12708

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

327

2.13

7.95

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

247

2.29

7.69

1.3

1.5

e6/l

70886.7

63838.1

0.05

147

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

169

2.57

7.58

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

169

2.57

7.58

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

169

2.57

7.58

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.44

7.39

1.6

2.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

156

982

1.62

7.31

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

212

1439

1.51

7.14

2.0

2.2

g/l

9.9

11.0

4.36

182

1301

(1761482) Bacteria [#/volume] in Urine by Culture

128

771

1.69

7.12

4.5

4.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1443

0.54

7.09

2.3

2.4

au/ml

10.7

28.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

227

2.27

6.90

2.9

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1006

11544

0.81

6.67

2.7

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

187

2.37

6.62

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

284

2.10

6.60

1.3

—

(3045788) Cell count panel - Pleural fluid

219

2.26

6.58

1.3

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

167

1098

1.55

6.54

2.0

1.8

—

(40761536) Microorganisms panel - Urine sediment

260

1869

1.43

6.53

3.6

4.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

101

590

1.73

6.32

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

101

590

1.73

6.32

1.4

1.3

—

(3019977) pH of Arterial blood

149

2.50

6.26

3.4

2.2

7.4

0.13

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.60

6.03

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1012

11523

0.82

6.03

2.1

pmol/l

90.2

93.4

1.38

628

5886

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

297

2.00

5.89

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.79

5.81

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

388

1.85

5.59

3.9

3.4

60.3

58.9

0.40

388

(3000492) Spirometry study

128

1938

0.65

5.54

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

216

2.15

5.54

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

134

2.48

5.53

3.1

1.7

nmol/l

17.1

15.9

0.38

116

(3024928) Oxygen saturation in Venous blood

553

1.70

5.51

2.4

2.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

258

1911

1.38

5.48

2.7

1.8

nmol/l

419.3

364.4

3.05

240

1702

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

625

0.40

5.43

1.5

1.7

mg/l

7.1

3.9

0.46

446

(3011648) Oxygen content in Venous blood

187

2.21

5.31

1.6

1.9

12.4

10.6

1.99

187

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

151

1026

1.49

5.14

2.0

1.7

—

(1002224) Polysomnography panel

634

0.42

5.07

1.0

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

240

1783

1.37

5.02

2.7

3.8

0.2

0.1

1.20

121

375

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

274

1.95

4.97

1.6

1.3

nmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.71

4.84

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

551

4597

1.24

4.82

4.0

4.2

—

(3008898) HLA-B27 [Presence]

520

0.38

4.79

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

119

2.45

4.79

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

120

2.43

4.71

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

229

1707

1.37

4.71

2.6

3.6

0.7

0.6

0.36

298

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.85

4.65

2.0

2.2

—

(3044889) 12 lead EKG panel

1603

17295

0.85

4.64

4.3

4.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

192

2.10

4.61

1.1

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

347

1.80

4.59

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

794

0.51

4.56

1.3

—

(3012516) Albumin [Mass/volume] in Urine

741

8511

0.83

4.55

2.8

3.2

mg/l

286.9

234.0

0.16

487

5394

(40768793) Breast Pathology biopsy report

117

2.41

4.47

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

280

3572

0.76

4.45

14.1

7.7

—

(3002385) Erythrocyte distribution width [Ratio]

1759

18805

0.86

4.40

45.1

17.2

14.9

13.8

134.98

1731

18247

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.24

4.35

1.3

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

771

6719

1.19

4.30

2.1

2.3

mg/l

3.1

3.0

0.55

680

5645

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

269

1.87

4.22

1.1

g/l

1.8

1.5

2.42

230

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

155

2141

0.71

4.19

1.4

1.3

—

(3035880) pH of Pleural fluid

121

2.33

4.17

1.1

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

499

4182

1.23

4.16

16.3

30.6

inr

1.3

1.5

1.32

563

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

278

1.85

4.14

1.6

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

2.21

4.11

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

995

0.59

4.11

1.2

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

106

704

1.52

4.09

4.7

3.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

8.02

4.06

1.0

1.1

—

35.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

280

1.83

4.05

1.1

1.4

u/ml

104.6

111.4

0.26

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

142

2.19

4.05

1.8

1.7

u/l

7515.3

1577.5

—

(40768800) Prostate Pathology biopsy report

189

2.02

4.03

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

627

5394

1.20

4.00

3.9

4.1

ng/l

202.0

466.4

1.33

511

4592

(3025159) Blasts/100 leukocytes in Blood

222

1691

1.34

4.00

2.8

3.9

0.0

0.3

0.65

101

326

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

321

1.76

3.88

1.1

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

779

1.48

3.86

1.8

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

307

1.77

3.85

1.6

1.3

nmol/l

0.6

0.7

1.40

295

(3012441) Differential panel - Pleural fluid

235

1.88

3.83

1.3

1.5

—

(3021788) Differential panel - Synovial fluid

496

0.44

3.82

1.8

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

6.01

3.81

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

6.01

3.81

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

6.01

3.81

1.2

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.80

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

8.77

3.77

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

436

0.41

3.74

1.4

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

209

1.93

3.72

1.1

1.3

—

(4094501)

690

0.53

3.71

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.51

3.71

1.1

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.51

3.71

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.51

3.71

1.1

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.51

3.71

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

2.06

3.70

3.6

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

465

1.61

3.66

1.3

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.54

3.63

2.0

2.1

17.4

14.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

156

2.06

3.61

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

523

1.56

3.59

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

558

1.54

3.51

2.3

2.4

14.2

16.2

2.89

294

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1147

0.65

3.50

1.1

1.2

iu/ml

224.0

118.1

0.88

421

(3000475) Leukocytes [#/volume] in Synovial fluid

701

0.55

3.48

1.5

e6/l

25786.6

14234.0

0.42

507

(21494815) CD4 cells/100 lymphocytes in Specimen

2.42

3.47

2.0

2.2

—

51.7

—

(3044290) Cell count panel - Cerebral spinal fluid

421

0.42

3.46

1.2

—

(3045424) Erythrocytes [Presence] in Urine

419

0.43

3.42

1.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

118

834

1.43

3.39

2.5

2.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

731

0.57

3.35

3.1

nmol/l

0.7

0.8

1.47

558

(3004588) Protein electrophoresis panel - Serum or Plasma

142

1913

0.73

3.34

2.1

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

495

0.48

3.31

1.1

1.2

—

0.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

307

1.71

3.30

1.7

1.3

nmol/l

0.2

0.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

219

1.84

3.27

2.3

3.1

—

(3037522) Nuclear Ab [Titer] in Serum

230

2889

0.78

3.27

1.3

titre

373.0

551.6

1.46

652

(3008295) Osmolality of Serum or Plasma

227

1.82

3.24

1.4

mosm/kgh2o

277.3

275.4

0.24

167

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

157

1.98

3.19

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

152

1.98

3.09

1.2

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2268

23575

0.87

3.09

36.7

14.5

mg/l

39.1

25.2

59.95

2159

18694

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.24

3.05

2.2

2.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.41

2.96

2.1

1.5

—

(3011412) CD3 cells [#/volume] in Blood

107

2.16

2.96

2.0

1.9

e9/l

1.1

1.0

0.24

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

446

0.49

2.93

1.1

1.2

u/l

17.4

22.4

0.37

389

(4010399)

136

1804

0.74

2.92

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

242

1953

1.26

2.89

5.1

2.4

ml/min/173m2

67.3

61.3

2.05

113

794

(3003181) Sodium [Moles/volume] in Urine

470

1.52

2.88

1.4

1.3

mmol/l

67.5

62.3

0.43

372

(3009508) Creatinine [Moles/volume] in Urine

781

8661

0.87

2.88

2.7

3.2

mmol/l

6.8

7.3

3.22

629

7175

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.10

2.88

1.2

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

522

5962

0.85

2.86

1.7

1.8

nmol/l

1192.0

1163.0

0.30

411

4448

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

208

1.79

2.82

1.1

u/l

50.0

56.4

0.58

134

(3015171) Extractable nuclear Ab [Units/volume] in Serum

854

0.64

2.82

1.2

u/ml

0.1

0.6

—

(1616796) Gas panel - Central venous blood

571

1.47

2.81

3.2

3.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

204

0.34

2.79

1.0

1.1

—

87.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

206

0.34

2.78

1.0

1.1

—

52.6

—

(3038026) Centromere Ab [Units/volume] in Serum

207

0.34

2.77

1.0

1.1

—

60.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.23

2.77

1.7

2.4

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

2.77

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

2.77

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

2.77

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

2.77

0.0

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

233

1.73

2.72

5.4

3.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

600

0.58

2.71

1.1

1.2

—

49.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

711

0.61

2.70

1.4

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.22

2.67

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.13

2.64

1.8

2.3

—

(3000330) Specific gravity of Urine by Test strip

183

1448

1.28

2.59

4.0

3.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

548

1.45

2.59

1.7

2.5

mg/l

1.5

1.7

2.51

478

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

641

0.60

2.58

1.5

1.6

iu/ml

21.2

4.9

0.35

147

(3041096) Erythrocytes [Presence] in Urine by Automated

675

6046

1.15

2.56

3.6

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

713

0.63

2.55

1.4

—

(3021589) Normoblasts [#/volume] in Blood

1088

10048

1.12

2.55

18.8

8.7

e9/l

0.0

0.79

863

8124

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.15

2.55

1.0

1.1

—

(4024509)

287

0.42

2.52

1.4

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

285

1.62

2.51

1.1

1.2

u/ml

252.6

278.6

0.27

175

(3004451) EKG impression Narrative

143

1.90

2.50

1.1

1.3

—

(40768443) Skin Pathology biopsy report

948

0.68

2.50

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.82

2.46

1.3

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.82

2.46

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

455

0.55

2.43

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

825

9029

0.88

2.43

3.5

4.0

mg/mmol

11.7

8.6

0.87

523

5717

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

220

0.41

2.42

1.0

1.1

—

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

568

0.59

2.42

1.4

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

659

1.39

2.38

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.42

2.36

1.2

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

3.64

2.36

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.12

2.36

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.51

2.35

2.4

3.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

140

1.86

2.31

1.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

247

2052

1.22

2.31

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

663

1.38

2.31

1.2

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

188

0.37

2.26

1.0

1.1

—

6.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

514

1.43

2.25

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.89

2.25

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

113

1.95

2.25

1.7

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

100

1329

0.74

2.24

1.8

2.1

nmol/l

12.5

14.6

1.84

1140

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

311

1.55

2.22

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.62

2.18

2.1

2.5

—

(3045414) Leukocytes [Presence] in Urine

1118

0.73

2.18

1.8

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

656

1.37

2.13

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

197

1.68

2.12

1.7

2.7

64.0

60.0

0.42

123

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

318

0.50

2.10

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.26

2.07

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.26

2.07

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.26

2.07

1.1

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

207

0.43

2.07

1.0

1.1

—

27.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

146

1161

1.27

2.05

1.7

1.4

g/l

0.9

1.1

3.38

133

1046

(3004616) Nuclear Ab [Presence] in Serum

300

0.50

2.01

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

924

9953

0.90

2.00

2.4

2.2

nmol/l

70.6

79.0

15.67

843

8614

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.03

1.95

2.5

2.8

—

(3016018) Differential panel - Cerebral spinal fluid

202

0.44

1.95

1.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.19

1.94

1.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

250

1.57

1.92

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1750

16747

1.10

1.92

4.2

4.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

550

6078

0.89

1.86

1.7

pmol/l

469.1

31985791.6

4.53

439

4921

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

343

0.55

1.86

1.4

72.1

65.2

0.32

226

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

309

1.50

1.85

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

199

0.45

1.83

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

401

1.43

1.82

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

343

1.46

1.82

1.9

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

898

0.73

1.79

1.5

1.8

u/l

38.3

38.0

0.04

758

(3007853) Bacteria identified in Skin by Aerobe culture

322

2810

1.16

1.78

1.7

1.8

—

(3016750) Collection duration of Urine

161

1.68

1.78

1.7

2.0

min

441.9

495.0

0.96

116

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.06

1.70

1.2

—

(44806420)

104

1.83

1.67

2.4

2.3

—

(3024263) Appearance of Synovial fluid

161

0.43

1.66

1.1

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

615

6707

0.90

1.65

1.6

nmol/l

20.1

20.2

0.00

567

5629

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

841

9023

0.91

1.64

2.8

3.2

ng/l

1405.6

1739.8

1.33

743

7773

(3042631) Mycobacterium sp identified in Specimen

327

1.44

1.62

2.2

3.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.87

1.60

1.0

1.5

umol/l

47.7

142.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

236

0.51

1.59

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

473

1.36

1.58

1.4

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

174

0.46

1.57

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

542

0.68

1.56

1.1

1.2

—

265.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

221

0.50

1.55

1.0

1.4

—

187.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.11

1.55

1.8

1.4

—

(3045142) Bone marrow Pathology biopsy report

176

1.60

1.54

1.4

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

466

0.66

1.50

1.1

—

(3023410) Appearance of Cerebral spinal fluid

183

0.49

1.50

1.1

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

600

1.31

1.49

3.2

2.7

kpa

8.2

7.8

1.20

559

(3036603) Volume of Urine

131

1.68

1.49

1.6

1.4

2013.0

1930.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.95

1.48

1.6

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.95

1.48

1.6

2.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

166

0.48

1.46

1.0

1.2

mmol/l

2.8

2.1

—

155

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

195

2275

0.85

1.45

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

148

1.63

1.44

2.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.73

1.43

2.0

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.04

1.43

1.3

1.5

pmol/l

15.3

15.6

0.09

(3010144) Erythrocytes [#/volume] in Synovial fluid

278

0.57

1.43

1.3

e6/l

27776.1

142071.5

—

198

(3017569) Oxygen content in Arterial blood

164

1.59

1.43

4.2

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

465

1.34

1.42

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.42

1.39

1.0

1.1

ng/l

61.8

113.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.42

1.39

1.7

1.5

—

(4034850)

922

0.78

1.34

13.4

10.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

854

0.77

1.33

3.1

1.5

mg/l

50.3

49.6

0.04

697

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

199

1720

1.17

1.30

3.3

3.6

kpa

5.1

5.2

1.23

176

1570

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

851

0.77

1.30

3.1

1.5

mg/l

31.4

43.1

0.93

691

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

234

1.46

1.29

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

180

1546

1.17

1.28

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

936

0.79

1.26

1.4

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

459

0.69

1.26

1.8

iu/l

3.0

4.3

0.83

137

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1000

0.79

1.24

2.2

1.4

g/l

3.3

3.0

1.28

767

(3009343) pH of Capillary blood

195

1692

1.16

1.23

3.3

3.6

7.4

0.11

205

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1072

0.81

1.20

2.1

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1072

0.81

1.20

2.1

1.4

g/l

7.5

0.07

780

(3047007) Chlamydophila sp Ab [Presence] in Serum

225

0.58

1.18

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

170

0.53

1.18

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1069

0.81

1.17

2.1

1.4

g/l

3.7

3.9

0.54

750

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

165

1.52

1.17

1.3

1.1

—

(3004775) Volume in Urine collected for unspecified duration

240

1.42

1.16

2.1

2.2

621.0

628.7

0.04

148

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

824

0.78

1.15

3.1

1.5

ratio

3.5

2.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

130

0.46

1.15

1.5

1.1

mg/l

84.1

38.4

—

111

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

360

1.34

1.15

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

1.14

0.0

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

196

0.56

1.12

1.7

1.3

—

26.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

897

0.80

1.11

2.3

1.5

g/l

0.9

0.6

0.54

758

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

286

1.37

1.08

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

849

0.80

1.08

2.3

1.4

g/l

37.2

37.4

0.12

701

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

187

1637

1.15

1.08

3.3

3.5

mmol/l

2.0

1.9

0.05

131

1185

(3004716) Salmonella sp identified in Stool by Organism specific culture

104

868

1.20

1.06

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

279

1.37

1.05

1.3

1.2

—

(3014891) Appearance of Pleural fluid

2.06

1.03

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

130

1.54

1.02

1.5

u/l

4.2

7.0

0.41

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

964

9186

1.07

1.02

4.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

108

0.46

1.00

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

294

2664

1.11

1.00

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

107

1.59

0.99

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

107

1.59

0.99

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

283

1.35

0.98

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

255

2827

0.89

0.98

2.3

2.4

ug/l

3.5

7.3

11.65

214

2417

(3044927) Protein electrophoresis panel - Urine

343

0.70

0.98

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.97

0.0

3.8

—

(4268621)

187

0.59

0.97

2.2

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

354

0.70

0.97

1.1

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

348

3189

1.10

0.96

2.1

1.9

1.8

1.38

323

2770

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

276

1.34

0.95

1.3

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

149

1.48

0.95

1.5

1.3

u/l

12.9

14.5

0.73

142

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

433

0.74

0.95

1.1

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

209

0.62

0.93

1.2

1.8

—

1.2

—

(3019225) pH of Specimen

287

2610

1.11

0.93

3.9

3.8

—

(21494434) Karyotype in Bone marrow

196

0.61

0.92

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

278

1.33

0.92

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

141

1613

0.87

0.90

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

168

1.43

0.89

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

0.49

0.89

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

160

1.44

0.88

4.0

2.7

—

(3017704) Immunofixation for Urine

155

0.58

0.88

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.86

0.87

1.0

1.5

u/l

30.4

53.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

205

0.63

0.87

1.0

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.94

0.84

1.3

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.76

0.83

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.74

0.82

1.6

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

455

0.77

0.82

1.4

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

1.51

0.82

1.1

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1001

0.85

0.81

2.1

1.4

g/l

9.9

10.4

0.63

826

(3025468) Yersinia sp identified in Specimen by Organism specific culture

277

1.30

0.78

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

122

0.57

0.78

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

118

1030

1.15

0.77

3.4

4.0

mmol/l

24.6

24.8

0.18

106

928

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

126

0.55

0.77

2.3

2.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.76

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

1.50

0.76

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

183

1.37

0.75

2.8

3.0

—

(4306422)

256

0.70

0.75

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

693

6599

1.06

0.75

3.9

4.2

estimate

0.0

0.69

231

1963

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1104

10658

1.05

0.75

3.9

4.1

ng/l

35.5

82.1

1.78

896

8066

(3051593) INR in Capillary blood by Coagulation assay

172

0.64

0.73

31.0

12.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.64

0.73

1.4

1.2

117.1

113.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

237

1.31

0.72

2.0

2.2

u/field

1.2

1.7

0.44

(3002619) Bacteria identified in Specimen by Culture

1.75

0.71

1.6

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

134

1.42

0.71

1.1

1.8

u/field

1.4

2.0

0.30

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

696

0.83

0.70

2.0

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.71

0.70

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.55

0.69

1.4

1.2

g/l

0.4

0.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.67

0.68

1.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

531

5598

0.94

0.68

4.1

4.3

kg/l

1.0

0.70

867

(4027681)

0.54

0.67

1.8

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.54

0.67

1.2

—

(3022313) Gas panel - Capillary blood

136

1216

1.12

0.65

3.3

3.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

220

2024

1.09

0.62

1.5

1.7

1.6

0.31

180

1701

(3029075) Extractable nuclear Ab panel - Serum

1.63

0.62

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.67

0.61

3.2

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

620

0.84

0.61

3.0

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.60

0.61

1.0

—

(3011985) Renin [Units/volume] in Plasma

308

1.24

0.59

1.6

1.3

mu/l

31.0

68.5

1.73

279

(3026389) Candida sp identified in Specimen by Organism specific culture

290

1.24

0.59

1.3

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

0.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.56

0.58

3.9

1.7

ug/l

0.9

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

2.1

—

19.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.58

0.0

1.1

—

21.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.51

0.58

1.0

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.72

0.57

1.0

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

149

0.67

0.56

5.6

3.9

15.0

13.3

—

149

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

189

2054

0.92

0.56

3.9

3.6

ng/l

84.0

96.9

1.37

159

1713

(3015183) Erythrocyte sedimentation rate

1.51

0.56

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

699

0.86

0.56

1.2

1.4

—

20.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.55

1.2

1.3

71.1

62.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

729

1.14

0.55

3.3

3.0

mmol/l

24.4

25.1

0.59

639

(3039162) Centromere protein B Ab [Units/volume] in Serum

262

0.76

0.54

1.3

1.2

—

39.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

781

0.87

0.53

2.0

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

1.52

0.52

1.7

1.8

—

(3006270) Folate [Moles/volume] in Blood

259

1.24

0.52

1.2

nmol/l

433.9

341.0

1.12

214

(3000012) Reticulocyte production index

154

0.71

0.47

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.46

0.46

2.0

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

290

2740

1.06

0.45

3.3

3.2

ng/l

198.2

241.0

1.06

267

2516

(44813793)

121

0.66

0.45

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.59

0.45

1.0

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

112

1.34

0.44

1.1

u/l

259.3

83.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

139

1.30

0.43

3.3

1.7

—

(3013512) EKG study

765

7883

0.96

0.43

4.4

4.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

113

1.33

0.42

1.1

u/l

114.1

24.9

—

(3017732) Neutrophils [#/volume] in Blood

164

1525

1.08

0.41

5.3

3.1

e9/l

4.3

4.2

0.23

127

1064

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

7.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3049717) Cytology report of Urine Cyto stain

881

1.10

0.41

2.8

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

220

2337

0.94

0.41

1.8

2.1

ug/g

124.5

173.4

1.39

179

1813

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

271

0.81

0.40

2.9

3.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

100

1096

0.91

0.40

2.3

2.9

pmol/l

4.2

4.4

0.71

935

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

792

0.89

0.39

2.3

1.4

g/l

0.0

0.31

717

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

0.68

0.39

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

1.41

0.39

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.39

0.0

1.2

—

(3025315) Body weight

0.00

0.39

0.0

3.9

—

(3019174) dRVVT (LA screen)

0.00

0.39

0.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.39

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.39

0.38

1.0

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

966

9446

1.03

0.35

2.5

2.8

ug/l

225.7

140.1

8.89

901

8553

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.65

0.35

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

0.62

0.35

1.0

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

122

0.74

0.35

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

0.74

0.35

1.0

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

208

2199

0.94

0.35

2.1

1.6

g/l

64.2

66.6

3.92

189

1940

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

126

0.71

0.35

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

349

1.15

0.33

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

424

0.87

0.33

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

275

1.17

0.32

2.5

3.0

mg/l

17.8

29.2

0.69

207

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

241

0.83

0.31

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

737

0.91

0.31

2.4

1.5

g/l

0.0

0.00

663

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.73

0.30

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

102

1.28

0.30

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

166

1.21

0.29

1.1

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

426

4396

0.96

0.28

1.2

u/ml

3.6

1.9

0.57

100

1125

(40757373) Influenza virus identified in Isolate

1.27

0.27

1.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

575

5899

0.97

0.27

3.5

3.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

720

0.91

0.27

2.4

1.5

g/l

0.0

0.00

659

(3022621) pH of Urine by Test strip

181

1722

1.05

0.27

2.9

3.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.21

0.26

1.3

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.21

0.26

1.6

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1221

12034

1.02

0.26

3.8

3.9

estimate

0.0

1.08

249

1966

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

127

0.79

0.25

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

361

0.89

0.24

1.9

2.5

—

(3021901) Oxygen saturation in Capillary blood

524

1.09

0.23

3.5

2.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.27

0.22

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1204

11885

1.02

0.22

5.1

5.2

estimate

0.0

0.50

265

2041

(3007164) IgA [Mass/volume] in Serum or Plasma

379

3686

1.03

0.22

1.5

1.3

g/l

2.6

2.7

0.39

228

2073

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.21

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

244.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.21

0.0

1.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.21

0.0

2.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.9

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

105

0.76

0.21

6.5

5.7

—

66.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

287

1.12

0.20

1.5

1.3

pmol/l

286.0

273.3

0.11

219

(3014051) Protein [Presence] in Urine by Test strip

584

0.92

0.20

2.0

2.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(4211845)

136

1.18

0.20

1.9

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

229

0.87

0.20

2.5

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

232

2399

0.96

0.20

1.3

—

(3020491) Glucose [Moles/volume] in Blood

193

1.14

0.19

2.2

2.5

mmol/l

7.1

6.9

0.12

127

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

298

1.11

0.19

1.2

miu/ml

215.2

209.9

—

112

(3032773) Endomysium IgG Ab [Titer] in Serum

154

0.84

0.19

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

618

1.07

0.18

1.9

2.1

g/l

116.2

130.3

4.12

463

(3011288) Drugs identified in Urine by Screen method

156

1.15

0.18

1.1

2.8

—

(3027944) Amphetamines [Presence] in Urine

232

1.12

0.18

1.2

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

919

0.95

0.18

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

153

0.85

0.18

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

153

0.85

0.18

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

153

0.85

0.18

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.21

0.17

2.1

2.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.75

0.17

1.0

1.1

86.8

91.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.78

0.15

1.0

1.2

—

0.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1199

11877

1.02

0.15

3.8

estimate

0.0

0.00

267

2023

(3027008) Opiates [Presence] in Urine

236

1.10

0.14

1.2

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

150

0.87

0.14

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

150

0.87

0.14

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

150

0.87

0.14

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

543

0.94

0.14

1.8

1.6

—

(4015189)

0.81

0.14

1.9

2.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

139

0.86

0.14

3.8

4.0

—

(3037121) Protein [Mass/volume] in Urine

822

1.05

0.14

2.1

2.6

g/l

0.2

0.3

0.69

279

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

587

1.06

0.14

1.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

150

1452

1.03

0.14

2.7

2.5

—

(3028300) Cannabinoids [Presence] in Urine

237

1.10

0.14

1.2

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

106

0.85

0.13

1.3

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

109

0.83

0.13

1.1

1.2

nmol/l

131.8

144.7

—

109

(3003327) Ova and parasites identified in Stool by Light microscopy

590

0.95

0.12

1.6

1.7

—

(3006462) Nitrate [Presence] in Urine

124

1.13

0.11

1.9

3.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

239

0.92

0.10

2.2

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.09

0.09

1.4

1.1

—

(3037756) Immunofixation for Serum or Plasma

513

0.95

0.09

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.09

0.08

1.2

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.07

0.08

11.7

7.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.05

0.08

1.0

1.1

—

(3034426) Prothrombin time (PT)

0.81

0.08

1.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

234

1.07

0.08

1.1

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

512

5071

1.01

0.08

1.9

1.7

mg/l

2.9

1.3

5.09

431

3931

(3025130) Human papilloma virus identified in Specimen

127

1.10

0.08

1.8

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

256

0.94

0.07

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.12

0.07

1.4

1.1

—

(3016879) Cocaine [Presence] in Urine

225

0.93

0.07

1.2

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

314

1.05

0.07

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

749

1.03

0.06

2.3

2.2

ug/min

82.2

103.5

0.28

430

(3047189) Immunofixation for 24 hour Urine

100

0.90

0.06

2.8

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

277

1.05

0.05

2.2

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

209

1.05

0.04

1.0

u/ml

11.7

2.4

—

(4146454)

332

0.96

0.04

2.8

—

(40761535) Cells panel - Urine sediment

234

2319

1.01

0.04

3.5

3.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

412

0.97

0.04

2.6

2.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

583

0.98

0.03

3.8

mg/l

41.0

29.6

1.35

396

(3023520) Reticulocytes [#/volume] in Blood

239

2409

0.99

0.03

2.0

2.2

e9/l

72.9

68.2

0.75

183

1851

(3000093) Morphology [Interpretation] in Blood Narrative

238

0.97

0.02

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

277

0.97

0.01

1.3

1.2

u/ml

5.0

2.7

—

(3022145) Colonoscopy Study observation

227

2278

1.00

0.01

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

174

1.03

0.00

1.3

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

266

0.98

0.00

1.2

u/ml

3.3

6.3

—

122

(40757494) Bilirubin.total [Moles/volume] in Blood

155

1.03

0.00

2.3

2.0

umol/l

130.5

19.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

185

1.03

0.00

1.2

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

111

0.99

0.00

1.1

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

119

1.01

0.00

1.8

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

126

1265

1.00

0.00

1.3

1.5

g/l

1.7

1.5

0.96

110

1075

(3002523) Influenza virus A Ag [Presence] in Specimen

176

1.02

0.00

1.3

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

0.97

0.00

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

103

0.97

0.00

1.4

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.90

0.00

1.7

2.1

u/ml

607.0

1031.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

5.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

3.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.00

0.00

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.93

0.00

10.9

7.2

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.92

0.00

4.2

6.5

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

393.7

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

7.2

—

(3020650) Glucose [Presence] in Urine

0.91

0.00

1.0

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.90

0.00

11.5

7.2

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

9.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.87

0.00

2.7

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

1.02

0.00

1.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.97

0.00

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1352.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.2

—

2.4

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PANCREAS_EXALLC – Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers) (C3_PANCREAS_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints